Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹615.50
3.55 (0.58%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.23K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
13.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹440+39.9%
52W High₹770-20.1%
Current Price
₹615.50
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹492.40
Upper Circuit₹738.60
Reference Price
₹615.50
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹683.8
Triple Bottom on 1W — target ₹730.8
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price below SuperTrend (Responsive Setting (Day Trading/Short-Term))
Composite score 13.41 (NEUTRAL) with 73.7% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
74%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
621.83
EMA50
628.05
EMA200
585.93
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows4
Lower Highs6
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹617.67
₹634.50
₹643.55
₹651.45
₹659.22
Support (Below)
₹600.87
₹583.35
₹565.26
₹544.17
₹534.80
Volume Analysis
TrendDECREASING
Change-69.20%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹609.35
3% Risk₹597.03
5% Risk₹584.73
7% Risk (Custom)
₹572.41Technical Levels
1x ATR (Volatility)₹594.53
2x ATR (Swing)₹573.56
3x ATR (Trend)₹552.59
Immediate Support₹600.87
Moving Averages
EMA 200 (Long-term)₹585.93
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹146.6 Cr | ₹160.2 Cr | ₹154.1 Cr | ₹163.4 Cr |
| Net Profit | ₹20.8 Cr | ₹11.6 Cr | ₹27.7 Cr | ₹20 Cr |
| EPS | ₹10.37 | — | ₹13.82 | ₹9.98 |
| Operating Profit | ₹32.6 Cr | ₹19.8 Cr | ₹39.1 Cr | ₹32.7 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Lincoln Pharmaceuticals Limited | ₹615.50 | +0.58% | 14.0 | ₹1.23K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 12 Sept 2025 | Dividend - Rs 1.80 Per Share | DIVIDEND |
| 13 Sept 2024 | Dividend - Rs 1.80 Per Share | DIVIDEND |
| 15 Sept 2023 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 15 Sept 2022 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 16 Sept 2021 | Dividend - Rs 1.50 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for LINCOLN
View All
neutral
Google News - Investing.com India 28d ago
Lincoln National options trading jumps to 2,601 contracts By Investing.com - Investing.com India
Lincoln National options trading jumps to 2,601 contracts By Investing.comInvesting.com India
LINCOLNHealthcare
NEWS
negative
Business Standard - Markets 42d ago
Jaykay Enterprises Ltd leads losers in 'B' group
Lincoln Pharmaceuticals Ltd, Rajdarshan Industries Ltd, Tolins Tyres Ltd and Raj Television Network Ltd are among the other losers in the BSE's 'B' group today, 29 May 2026.
ARENTERPBSEJAYKAYLINCOLNRAJTVTOLINSTVTODAYAutomobile and Auto ComponentsCapital Goods
positive
ET Markets - Industry 43d ago
Lincoln Pharmaceuticals posts Rs 11.63 crore profit for Q4
Lincoln Pharmaceuticals announced a slight profit rise for the fourth quarter ending March 31, 2026. Full fiscal year 2025-26 saw over 6 percent growth in consolidated net profit. Revenue from operations also increased year-on-year. The company's board recommended an 18 percent dividend. Lincoln Pharmaceuticals targets Rs 1,000 crore revenue in three years.
DIVIDENDLINCOLNMOGSECFinancial ServicesHealthcare